Mohammad Moein Sadeghi

Mr. Mohammad Moein Sadeghi

Department of Pharmaceutical Sciences, Qatar University, Doha, Ad Dawḩah, Qatar
+1
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2022 in Industrial & Engineering Chemistry Research
Verified
Journal Article
Open access
Mohammad Tavakkoli YarakiMohammad Tavakkoli Yaraki
Mohammad Tavakkoli Yaraki
SNShima Zahed Nasab
Shima Zahed Nasab
IZIman Zare
Iman Zare
MDMohammad Dahri
Mohammad Dahri
Mohammad Moein SadeghiMohammad Moein Sadeghi
Mohammad Moein Sadeghi
Yen Nee TanYen Nee Tan
Yen Nee Tan

19 March 2022 in Virology Journal
Verified
Journal Article
Open access
PDF file
NANahid Alimoradi
Nahid Alimoradi
MSMoein Sharqi
Moein Sharqi
DFDena Firouzabadi
Dena Firouzabadi
Mohammad Moein SadeghiMohammad Moein Sadeghi
Mohammad Moein Sadeghi
MMMohammad Iman Moezzi
Mohammad Iman Moezzi
NFNegar Firouzabadi
Negar Firouzabadi
COVID-19 and the renin-angiotensin system (RAS) are linked by angiotensin-converting enzyme 2 (ACE2), a key enzyme in RAS that has been validated as a SARS-CoV-2 receptor. Functional ACE1/ACE2 gene polymorphisms may lead to the imbalance between ACE/ACE2 ratio and thus generating RAS imbalance that is associated with higher degrees of lung damage in ARDS that may contribute to the COVID-19 infection outcome. Herein, we investigated the role of RAS gene polymorphisms, ACE1 (A2350G) and ACE2 (G8790A) as risk predictors for susceptibility and severity of COVID-19 infection. A total of 129 included: negative controls without a history of COVID-19 infection (n = 50), positive controls with a history of COVID-19 infection who were not hospitalized (n = 35), and patients with severe COVID-19 infection who were hospitalized in the intensive care unit (n = 44). rs4343 of ACE and rs2285666 of ACE2 were genotyped using PCR–RFLP method. Our results indicated that susceptibility to COVID-19 infection was associated with age, GG genotype of A2350G (Pa = 0.01; OR 4.7; 95% CI 1.4–15.1 and Pc = 0.040; OR 2.5; 95% CI 1.05–6.3) and GG genotype of G8790A (Pa = 0.044; OR 6.17; 95% CI 1.05–35.71 and Pc = 0.0001; OR 5.5; 95% CI 2.4–12.4). The G allele of A2350G (Pa = 0.21; OR 1.74; 95% CI 0.73–4.17 and Pc = 0.007; OR 2.1; 95% CI 1.2–3.5) and G allele of G8790A (Pa = 0.002; OR 4.26; 95% CI 1.7–10.65 and Pc = 0.0001; OR 4.7; 95% CI 2.4–9.2) were more frequent in ICU-admitted patients and positive control group. Also lung involvement due to COVID-19 infection was associated with age and the comorbidities such as diabetes. In conclusion, our findings support the association between the wild genotype (GG) of ACE2 and homozygote genotype (GG) of ACE1 and sensitivity to COVID-19 infection, but not its severity. However, confirmation of this hypothesis requires further studies with more participants.

24 July 2025 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
MDMohammad Dahri
Mohammad Dahri
MRMilad Rezaeian
Milad Rezaeian
HSHadi Sadeghzadeh
Hadi Sadeghzadeh
NBNima Beheshtizadeh
Nima Beheshtizadeh
Mohammad Moein SadeghiMohammad Moein Sadeghi
Mohammad Moein Sadeghi
KAKhosro Adibkia
Khosro Adibkia
Macrophages are pivotal regulators of immunity, playing dual roles in both propagating and resolving inflammation through their remarkable plasticity. Their ability to polarize into pro-inflammatory (M1) or anti-inflammatory (M2) phenotypes makes them attractive targets for treating diseases ranging from cancer to chronic inflammatory disorders. However, precise control over macrophage polarization remains a therapeutic challenge. Recent advances in nanomaterial engineering have unlocked unprecedented opportunities to direct macrophage polarization with high specificity, offering novel strategies for immunomodulation and tissue repair. This review systematically examines the latest breakthroughs in nanomaterial-driven macrophage reprogramming, focusing on how tailored physicochemical properties (e.g., size, surface charge, and composition) of organic, inorganic, and hybrid nanoparticles influence phenotypic outcomes. We highlight key signaling pathways (e.g., NF-κB, STAT, TLR) and biomarkers (e.g., cytokines, metabolic shifts) modulated by nanomaterials, linking these mechanisms to therapeutic applications in cancer immunotherapy, infectious diseases, and regenerative medicine. Furthermore, we discuss emerging trends such as stimuli-responsive nanomaterials and combination therapies that enhance spatiotemporal control over polarization. By bridging gaps between nanotechnology and immunology, this work not only catalogs current achievements but also outlines future directions for precision nanomedicine, advocating for clinically translatable solutions to harness macrophage plasticity for disease therapy.

3 September 2021 in Drug Delivery and Translational Research
Verified
Journal Article
Open access
PDF file
MKMohammad Khedri
Mohammad Khedri
RMReza Maleki
Reza Maleki
MDMohammad Dahri
Mohammad Dahri
Mohammad Moein SadeghiMohammad Moein Sadeghi
Mohammad Moein Sadeghi
SRSima Rezvantalab
Sima Rezvantalab
Mohammad-Ali ShahbaziMohammad-Ali Shahbazi
Mohammad-Ali Shahbazi
In late 2019, coronavirus disease 2019 (COVID-19) was caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Spike protein is one of the surface proteins of SARS-CoV-2 that is essential for its infectious function. Therefore, it received lots of attention for the preparation of antiviral drugs, vaccines, and diagnostic tools. In the current study, we use computational methods of chemistry and biology to study the interaction between spike protein and its receptor in the body, angiotensin-I-converting enzyme-2 (ACE2). Additionally, the possible interaction of two-dimensional (2D) nanomaterials, including graphene, bismuthene, phosphorene, p-doped graphene, and functionalized p-doped graphene, with spike protein is investigated. The functionalized p-doped graphene nanomaterials were found to interfere with spike protein better than the other tested nanomaterials. In addition, the interaction of the proposed nanomaterials with the main protease (Mpro) of SARS-CoV-2 was studied. Functionalized p-doped graphene nanomaterials showed more capacity to prevent the activity of Mpro. These 2D nanomaterials efficiently reduce the transmissibility and infectivity of SARS-CoV-2 by both the deformation of the spike protein and inhibiting the Mpro. The results suggest the potential use of 2D nanomaterials in a variety of prophylactic approaches, such as masks or surface coatings, and would deserve further studies in the coming years.Graphical abstract

20 September 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MDMohammad Dahri Dahroud
Mohammad Dahri Dahroud
Mohammad Moein SadeghiMohammad Moein Sadeghi
Mohammad Moein Sadeghi
SASamira Sadat Abolmaali
Samira Sadat Abolmaali
The COVID-19 causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has a critical surface protein called spike protein (S protein), which is the target of many vaccines and drugs developments. Among non-structural proteins of SARS-CoV-2, main protease (Mpro) has drawn much attention to itself for designing antiviral drugs since it is very crucial for the virus replication in host cells. In the first part of the present study, the application of metal–organic frameworks (MOFs), one of the developing nanomaterials in the deformation and consequently inhibition of S protein binding to the receptor, angiotensin-converting enzyme 2 (ACE 2), is investigated. In this line, various S protein inhibitors were designed virtually, including ZIF, UIO, and IRMOF that their interactions with S protein and were investigated using molecular dynamics (MD) simulation. The results revealed that ZIF is the best candidate among the investigated MOFs with the least amount of energy interference with S protein. In the second part, the interaction of three-dimensional (3D) MOFs (such as ZIF, IRMOF, and HKUST) with SARS-CoV-2 Mprowas investigated. HKUST had the most potent interaction with Mproand showed more promise in deforming this protein's secondary structure among all materials tested. Furthermore, we investigated the interaction of HKUST-OH with Mproto determine the effect of functionalization. The findings of this study could be used in future studies to introduce bioconjugates of MOFs and biological molecules (e.g., antibody or nanobody) or to use MOFs as carriers for antiviral drug delivery.

11 December 2024 in BioNanoScience
Verified
Journal Article
Closed access
PDF file
Mohammad Moein SadeghiMohammad Moein Sadeghi
Mohammad Moein Sadeghi
SAShohreh Alipour
Shohreh Alipour
MMMohammad Hossein Morowvat
Mohammad Hossein Morowvat
SDSabya Sachi Das
Sabya Sachi Das
ADAli Dehshahri
Ali Dehshahri